TP53 and acute myeloid leukemia: All classes of TP53 mutations have been reported in patients with TP53m-AML, but nearly all occur in the DNA-binding domain (encoded by exons 5–8), and the vast majority will be missense mutations, which occur in 80–90% of cases [13,14,15].